Winning The HIV War: New Monthly Injections With Better Outcome To Replace Daily Pills

Long-acting Antiretroviral Injection Safe and as effective as Daily Oral Medication for HIV
An injectable antiretroviral therapy (ART) consisting of two drugs (cabotegravir and rilpivirine) administered every four or eight weeks may be as effective as a daily oral dose of the drugs in maintaining viral suppression in patients with HIV, according to a new phase 2 trial published in The Lancet.

HIV Disease - An Overview of Causes, Symptoms, Treatment and Key Facts

The Human immunodeficiency virus (HIV) is a blood-borne virus typically transmitted via sexual intercourse, shared intravenous drug paraphernalia, and mother-to-child transmission (MTCT), which can occur during the birth process or during breastfeeding. HIV disease is caused by infection with HIV-1 or HIV-2, which are retroviruses in the Retroviridae family, Lentivirus genus.

HIV PrEP-related Drug Resistance Disappears After Drug Is Stopped

Drug resistance acquired in rare cases of HIV infection during treatment with pre-exposure prophylaxis (PrEP) rapidly disappears once medication is discontinued, investigators report in AIDS. Use of ultra-sensitive tests performed six months after seroconversion and discontinuation of PrEP failed to find any resistant virus.

World AIDS Day - 1 December 2015

The world has come a long way since 2000, achieving the global target of halting and reversing the spread of HIV.

Accelerate Expansion of Antiretroviral Therapy to All People Living With HIV -- WHO

World AIDS Day WHO emphasizes that expanding antiretroviral therapy to all people living with HIV is key to ending the AIDS epidemic within a generation.

Treat All People Living With HIV, Offer Antiretrovirals as Additional Prevention Choice for People at "Substantial" Risk

Anyone infected with HIV should begin antiretroviral treatment as soon after diagnosis as possible, WHO announced Wednesday. With its "treat-all" recommendation, WHO removes all limitations on eligibility for antiretroviral therapy (ART) among people living with HIV; all populations and age groups are now eligible for treatment.

WHO Confirms Cuba Is First Country To Eliminate Mother-to-Child HIV and Syphilis Transmission

The World Health Organization on Tuesday declared Cuba the first country in the world to eliminate the transmission of HIV and syphilis from mother to child.

WHO Guideline on Use of Antiretrovirals by HIV-Negative People At High Risk To Prevent Infection

WHO'S FIRST EVER GUIDANCE ON ARV USE FOR INFECTION PREVENTION

On 20th July 2012, the WHO issued its first ever guidance to countries that are considering offering HIV medications, known as antiretrovirals (ARVs), to protect people who do not have the virus but who are at high risk of HIV infection.

Pre-exposure Chemoprophylaxis Reduces HIV Infections in Gay and Bisexual Men

A combination of oral antiretroviral therapy for preexposure chemoprophylaxis (PrEP) against HIV demonstrates moderate effectiveness in a major, multicontinent clinical trial that heralds a new — and expensive — means of curbing the spread of AIDS.

Gel to Reduce Risk of AIDS in Women Discovered

A woman's risk of infection with the AIDS virus can be significantly cut by the use of a vaginal gel, a study has found. The research marks the first success in a 15-year search for a way women can independently protect themselves from contracting HIV infection through sex.

Antiretroviral Therapy for HIV/AIDS

Standard highly active antiretroviral therapy (HAART) consists of the use of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease.